‘Investee’ Eye: Quanta CEO’s Perspective Of Seeking And Obtaining $245m Raise
Executive Summary
Quanta CEO John Milad outlines the transitional stage where a company begins to seek large-scale funding for the first time, and debates market valuations.
You may also be interested in...
Getting A Head Start: Medtech VC Aims Earlier Than Ever Before
As the value of medtech deals increases, investors are increasingly looking for earlier opportunities. COVID-19 has added both impetus and new opportunity, with innovators and investors vying to build a position in digital health technologies, such as remote monitoring and digital therapeutics.
Quanta Raises $245M In Series D, Plans To Expand Into Home-Based Dialysis In US
UK-based Quanta will use the proceeds to ramp up European commercialization and bring its SC+ portable hemodialysis system to US-based acute and chronic care facilities, but ultimately hopes to enter the rising US home-based dialysis market.
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.